For: | Kontoghiorghes GJ. New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer. Int J Mol Sci 2022;23. [PMID: 36430469 DOI: 10.3390/ijms232213990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Kontoghiorghes GJ. Deferiprone and Iron-Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects. Int J Mol Sci 2023;24. [PMID: 36902402 DOI: 10.3390/ijms24054970] [Reference Citation Analysis] |
2 | Ben Moftah M, Eswayah A. Hydroxyurea as a promising ADAM17 inhibitor. Medical Hypotheses 2023. [DOI: 10.1016/j.mehy.2023.111021] [Reference Citation Analysis] |